 BioSig Technologies Inc, which is commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, has announced the appointment of Dr James Barry as an independent board director. The company said Dr Barry has more than 30 years of experience in the medical device industry as an executive and corporate board director. 